Study of AWT020 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an investigational drug called AWT020 for people with advanced solid tumors that have grown after standard treatment. The goal is to see if AWT020 can help shrink or control the cancer, and it might be an option for you if other treatments haven't worked or aren't suitable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a solid tumor that is advanced and cannot be removed by surgery, and it must have grown after at least one prior treatment.
- You must have at least one measurable tumor (as per RECIST criteria) and be in good enough health to participate (day-to-day activities are possible, life expectancy at least 3 months).
- Your organ functions (bone marrow, kidneys, liver, heart, blood clotting) must be within acceptable limits.
- You cannot have brain metastases that are untreated or unstable, serious autoimmune disease, or ongoing lung inflammation.
- You must not have had certain previous treatments or conditions that could interfere with the study, and you must be willing to provide tumor tissue (if available).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called LAT010 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective.
This trial tests a new drug, AWT020, for people with advanced cancer (solid tumors or lymphoma) that hasn't responded to other treatments. The goal is to see if it is safe and how well it works.
This study tests an experimental drug called AWT020 in people with advanced cancers that have either stopped responding to standard treatments or aren't candidates for them. The goal is to see if AWT020 is safe and tolerable across several cancer types such as lung cancer, melanoma, colorectal cancer, kidney cancer, and others.
This trial tests an experimental drug called IPN01203 for people with advanced solid tumors that have grown after prior immunotherapy. The goal is to see if the drug is safe and can shrink tumors.
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
This trial tests a new study drug, GV20-0251, for people with advanced solid tumors that no longer respond to standard therapies. It aims to see if the drug can shrink tumors or slow their growth.
Hear when a new Advanced Cancers (Solid Tumors) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.